tirzepatide medicine is a New Medication for Diabetes and Weight Loss Users of Zepbound or Mounjaro

While palpitations are not a typical side effect, addressing common adverse reactions and maintaining overall health can reduce the likelihood of secondary complications that might manifest as cardiac symptoms

Dulaglutide gained FDA approval on September 18, 2014, under the brand name Trulicity

Cuomo A, Bolognesi S, Goracci A, Ciuoli C, Crescenzi BB, Maina G, et al

However, the exact pathogenic mechanism by which GLP-1 RAs elevate the risk of NAION remains unclear

A good pharmacy should have robust processes for maintaining the quality and safety of their products

If side effects persist or worsen, your provider may pause escalation, reduce the dose, or adjust the administration timing